What Pharma Can Learn from Patients: A Global Patient Advocate Survey
In June we asked Pharma what one question they’d ask patient advocates about trial participation. Through partnering with MK&A eyeforpharma has been able to send the questions to patient advocates across the globe. Now we have the results. Scroll down to read the findings with in depth analysis from Merck, the FDA and Horizon Pharma.
The whitepaper was conducted through research for Patient Centered Clinical Trials, the 3rd annual summit focused on harnessing the power of patients.
Enter your details on the right to find out more.>>